Persistent constipation, dizziness, vomiting, dehydration, severe abdominal pain, or fainting should always be discussed with a qualified healthcare provider
Understanding Individual Response: When Nausea Signals a Need for Personalized Adjustment Not all GLP-1 users experience nausea equally
[28] [29] Patients should maintain open communication with their healthcare team, report new symptoms promptly, and never discontinue prescribed medications without medical guidance
If using for high blood sugar: If you have type 1 diabetes
In the main 80-week trial, the highest dose produced an average weight loss of 28.3% among people who stayed on treatment, and 25.0% when everyone who started is counted
Kidney or liver conditions